These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12407303)

  • 1. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
    Dalakas MC
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory, immune, and viral aspects of inclusion-body myositis.
    Dalakas MC
    Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of inclusion body myositis.
    Cherin P
    Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
    Dalakas MC; Rakocevic G; Shatunov A; Goldfarb L; Raju R; Salajegheh M
    Ann Neurol; 2007 May; 61(5):466-75. PubMed ID: 17366634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.
    Figarella-Branger D; Civatte M; Bartoli C; Pellissier JF
    Muscle Nerve; 2003 Dec; 28(6):659-82. PubMed ID: 14639580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
    Amemiya K; Granger RP; Dalakas MC
    Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body myositis (IBM).
    Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
    Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
    Wójcik S; Engel WK; McFerrin J; Askanas V
    Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion body myositis: an underdiagnosed myopathy of older people.
    Munshi SK; Thanvi B; Jonnalagadda SJ; Da Forno P; Patel A; Sharma S
    Age Ageing; 2006 Jan; 35(1):91-4. PubMed ID: 16364943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects.
    Engel WK; Askanas V
    Neurology; 2006 Jan; 66(2 Suppl 1):S20-9. PubMed ID: 16432141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.